MaesTTRo A Non-interventional, Prospective, Multi-country Study Collecting Real-world Data on the Characteristics, Treatment Patterns, and Outcomes of Patients with Amyloid Transthyretin (ATTR) Amyloidosis
Research Grant
Awarded By
AstraZeneca AB
Start Date
December 16, 2024
End Date
December 31, 2032
Awarded By
AstraZeneca AB
Start Date
December 16, 2024
End Date
December 31, 2032